Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Huiling Chen, Xuan Ren, Shi Xu, Dekui Zhang & TiYun Han. (2022) Optimization of Lipid Nanoformulations for Effective mRNA Delivery. International Journal of Nanomedicine 17, pages 2893-2905.
Read now
Read now
Jinjie Zhang, Shuaishuai Wang, Huijie Cai, Tiange Feng, Zhilei Liu, Yaru Xu & Jianbo Li. (2021) Hydrophobic ion-pairing assembled liposomal Rhein with efficient loading for acute pancreatitis treatment. Journal of Microencapsulation 38:7-8, pages 559-571.
Read now
Read now
Articles from other publishers (17)
Kaushik Thanki, Tushar Date & Sanyog Jain. (2021) Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug Delivery. ACS Biomaterials Science & Engineering 9:6, pages 2879-2890.
Crossref
Crossref
Huijun Ma, Anran Qian, Yazhou Zheng, Xin Meng, Ting Wang, Yinyong Zhang, Lulu Sun, Feng Zou, Bomei Zhao, Shuhua Zhang, Dan Zhang & Yushe Yang. (2022) Design, Synthesis, and Structure–Activity Relationship Studies of Bisamide Derivatives of Amphotericin B with Potent Efficacy and Low Toxicity. Journal of Medicinal Chemistry 65:13, pages 8897-8913.
Crossref
Crossref
Alyaa A. Albadr, Ismaiel A. Tekko, Lalitkumar K. Vora, Ahlam A. Ali, Garry Laverty, Ryan F. Donnelly & Raghu Raj Singh Thakur. (2021) Rapidly dissolving microneedle patch of amphotericin B for intracorneal fungal infections. Drug Delivery and Translational Research 12:4, pages 931-943.
Crossref
Crossref
Peter Walde & Sosaku Ichikawa. (2021) Lipid Vesicles and Other Polymolecular Aggregates—From Basic Studies of Polar Lipids to Innovative Applications. Applied Sciences 11:21, pages 10345.
Crossref
Crossref
Kishor M. Wasan, Ellen K. Wasan & Peter Hnik. (2020) Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle Dogs. Antimicrobial Agents and Chemotherapy 64:11.
Crossref
Crossref
Raquel Fernández-García, Larry Statts, Jéssica A. de Jesus, Maria Auxiliadora Dea-Ayuela, Liliana Bautista, Rúben Simão, Francisco Bolás-Fernández, Maria Paloma Ballesteros, Marcia Dalastra Laurenti, Luiz F. D. PasseroAikaterini Lalatsa & Dolores R. Serrano. (2020) Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases. ACS Infectious Diseases 6:10, pages 2647-2660.
Crossref
Crossref
Peter Hnik, Ellen K. Wasan & Kishor M. Wasan. (2020) Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration. Antimicrobial Agents and Chemotherapy 64:10.
Crossref
Crossref
Filipa Sousa, Domingos Ferreira, Salette Reis & Paulo Costa. (2020) Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources. Pharmaceuticals 13:9, pages 248.
Crossref
Crossref
María Álvarez-Bardón, Yolanda Pérez-Pertejo, César Ordóñez, Daniel Sepúlveda-Crespo, Nestor M. Carballeira, Babu L. Tekwani, Sankaranarayanan Murugesan, Maria Martinez-Valladares, Carlos García-Estrada, Rosa M. Reguera & Rafael Balaña-Fouce. (2020) Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Marine Drugs 18:4, pages 187.
Crossref
Crossref
Gerard M. Jensen & Donald F. Hodgson. (2020) Opportunities and challenges in commercial pharmaceutical liposome applications. Advanced Drug Delivery Reviews 154-155, pages 2-12.
Crossref
Crossref
Sanket Shah, Vivek Dhawan, René Holm, Mangal S. Nagarsenker & Yvonne Perrie. (2020) Liposomes: Advancements and innovation in the manufacturing process. Advanced Drug Delivery Reviews 154-155, pages 102-122.
Crossref
Crossref
Camino Gutiérrez-Corbo, Raquel Álvarez-Velilla, Rosa M. Reguera, Carlos García-Estrada, Mark Cushman, Rafael Balaña-Fouce & Yolanda Pérez-Pertejo. (2019) Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum. International Journal for Parasitology: Drugs and Drug Resistance 11, pages 39-48.
Crossref
Crossref
Kaushik Thanki, Tushar Date & Sanyog Jain. (2019) Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach. Molecular Pharmaceutics 16:11, pages 4519-4529.
Crossref
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Crossref
Grace Cuddihy, Ellen Wasan, Yunyun Di & Kishor Wasan. (2019) The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?. Pharmaceutics 11:3, pages 99.
Crossref
Crossref
Ana Tejería, Yolanda Pérez-Pertejo, Rosa M. Reguera, Rubén Carbajo-Andrés, Rafael Balaña-Fouce, Concepción Alonso, Endika Martin-Encinas, Asier Selas, Gloria Rubiales & Francisco Palacios. (2019) Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents. European Journal of Medicinal Chemistry 162, pages 18-31.
Crossref
Crossref
Silvia Franzé, Francesca Selmin, Elena Samaritani, Paola Minghetti & Francesco Cilurzo. (2018) Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics 10:3, pages 139.
Crossref
Crossref